Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Clinical Data
Special Reports
2021's top 10 clinical trial flops
Thousands of studies are registered each year, so there is always an array of disappointing results to choose from for our annual Top 10 list.
Phil Taylor
Mar 1, 2022 3:00am
Gilead, Arcus hope to ease TIGIT anxieties with new data tease
Nov 28, 2022 11:20am
CinCor's hypertension drug loses halo after phase 2 fail
Nov 28, 2022 10:35am
Mesoblast sees cell therapy survival data as key to resubmission
Nov 23, 2022 9:30am
Pfizer's $1B protein degradation bet yields 3% response rate
Nov 22, 2022 9:40am
Khondrion forges on despite phase 2 mitochondrial disease fail
Nov 22, 2022 4:50am
More News
Lysogene's lead gene therapy fails phase 2/3 trial with cash low
Nov 18, 2022 3:12pm
MEI, Kyowa confirm phase 2 cancer efficacy with fresh data drop
Nov 18, 2022 9:35am
Inovio drops Lassa, MERS vaccines as clinical data fall short
Nov 18, 2022 5:25am
Editas shelves lead asset after disappointing phase 1/2 data
Nov 17, 2022 10:22am
See more
